Response of Liver Function Tests to Aerobic Exercise in Patients with Type 2 Diabetes Mellitus
|
|
- Prudence Cole
- 6 years ago
- Views:
Transcription
1 Med. J. Cairo Univ., Vol. 78, No. 2, March: 91-95, 21 Response of Liver Function Tests to Aerobic Exercise in Patients with Type 2 Diabetes Mellitus YASSER M. ABD EL-HAMID, M.D.* and AZA F. ISMAIL, M.D.** The Departments of Internal Medicine, Faculty of Medicine* and Cardiopulmonary Disorders & Geriatric Medicine, Faculty of Physical Therapy**, Cairo Uineversity. Abstract Background: The importance of aerobic exercise in the management of type 2 diabetes is well known. Liver function abnormalities are highly prevalent in diabetic patients due to high prevalence of non alcoholic steatohepatitis (NASH). Aim of Work: To study the short term effects of light intensity exercise on liver function biochemical tests in patients with type 2 diabetes. Subjects and Methods: Included patients were 5 type 2 diabetic patients and 2 normal controls. Diabetic patients were 2 males and 3 females, mean age was 43.9 ±8.6y. Mean BMI was 32.7± 1.3 kg/m 2. Control group consisted of 9 males and 11 females, mean age was 41.4 ±5.5y and mean BMI was 32.5±.4 kg/m 2. All patients and controls were subjected to light intensity bicycle based exercise for 2 minutes. A blood sample was withdrawn immediately before and immediately after exercise for assessment of serum AST, ALT, GGT, Alkaline phosphatase (Alk P), Total protein (TP) and albumin. Results: Liver enzymes were found to be significantly higher in diabetic patients than in controls while serum albumin and total proteins were found to be significantly lower in diabetics both pre exercise and post exercise. Mean values of all liver function tests studied were found to be significantly higher post exercise in both diabetic patients and control group. Mean values of percent of changes of liver enzymes were significantly higher in control group than in diabetic patients while total proteins and albumin were found to be significantly higher in diabetic patients than in controls. Conclusion: Light form exercise can cause immediate elevation of AST, ALT, GGT, Alkaline phosphatase, serum total proteins and albumin levels both in type 2 diabetic patients and in non diabetic subjects. No clear immediate effect of diabetes mellitus on changes of liver function tests post exercise could be detected. Key Words: Exercise Aerobic Diabetes Liver Enzymes. Correspondence to: Dr. Yasser M. Abd El-Hamid, Dept. of Internal Medicine, Faculty of Medicine, Cairo Uineversity. Introduction DATA concerning the role of exercise in hepatic disorders are unclear. Post exercise changes in serum liver enzymes showed elevation in AST, ALT, GGT and alkaline phosphatase [1]. Liver function tests were significantly increased after weightlifting [2]. Another study found no increase in serum AST and ALT in patients with type 2 diabetes post exercise [3]. Hypoxia caused by the acute effect of exercise was postulated to explain hepatic affection post exercise which could be reflected on liver function tests [4]. On the other hand, people who exercise on regular basis not only feel better, but often respond more positively to medical treatment. In many cases, regular exercise delay the onset of complications associated with liver disease [5] Moreover, regular exercise can be a valuable tool in the treatment of NASH and was found to improve liver functions and histology [6]. The possible benefits of physical activity for patients with type 2 diabetes are substantial and many studies proved the importance of long term physical activity programs both in prevention and treatment of type 2 diabetes [7]. Many forms of exercise, ie, aerobic, resistance, or combined training, were found to be equally beneficial in reducing HbA 1 C values [8]. It has been reported that insulin stimulation of IRS-1 phosphrylation and PI3 kinase activity are decreased while insulin action is enhanced following exercise. The post exercise increase in insulin action is observed equally both in insulin resistant and insulin sensitive states [9]. The liver helps to maintain normal blood glucose concentration in the fasting and postprandial states. Type 2 diabetes and glucose intolerance are very frequent in patients with NAFLD and they have 91
2 92 Response of Liver Function Tests to Aerobic Exercise prognostic significance [1]. Type 2 diabetes is a well known extrahepatic complication of HCV infection [11]. The aim of this work was to study the short term effects of light intensity exercise on liver function biochemical tests in patients with type 2 diabetes mellitus. Subjects and Methods This study was done on 7 subjects who were divided into two groups, group 1 included 5 patients with type 2 diabetes mellitus and group 2 consisted of 2 normal subjects. Demographic characteristics of patients are illustrated in Table (1). Table (1): Demographic and laboratory characteristics of diabetic patients and control subjects. Comparisons between two groups are illustrated. Variable Group 1 (n=5) Group 2 (n=2) Age (y) (mean±sd) 43.8± ±5.4.9 Sex: Males (n %) 2 (4%) 9 (45%) Females (n %) 3 (6%) 11 (55%) BMI (kg/m 2 ) (mean±sd) 32.7± ±.4.3 FBG (mg/dl) (mean±sd) 171.4± ± AST (n= -3 7 IU/L): Pre-exercise (mean±sd) 4.6± ±7.8.4 Post-exercise (mean ±SD) 45.4± ± ALT (n=-41 IU/L): Pre-exercise (mean±sd) 37.9± ±9.6.6 Post-exercise (mean ±SD) 4.4± ±9.4.1 GGT (n=8-61iu/l): Pre-exercise (mean±sd) 57.6± ±9.5.1 Post-exercise (mean ±SD) 61.7± ±9.4.1 Alk p (n= IU/L): Pre-exercise (mean±sd) 13.2± ± Post-exercise (mean ±SD) 17.2± ± T. protein (n= g/dl): Pre-exercise (mean±sd) 7.6± ±.6.4 Post-exercise (mean ±SD) 7.45± 1.7 8±.6.3 Albumin (n=3.5-5 g/dl): Pre-exercise (mean±sd) 3.2± ±.4.1 Post-exercise (mean ±SD) 3.5± ±.5.1 p Included patients were all suffering from type 2 diabetes mellitus more than 2 years of diagnosis. Exclusion criteria: The following patients were excluded; patients known to have hepatic disorders, cardiopulmonary diseases, severe diabetic neuropathy, retinopathy or peripheral vascular disease, patients with positive rapid test for HBsAg and HCV antibodies, patients receiving thiazolidinediones for control of blood sugar and patients with blood glucose level (15 mg/dl > fasting blood glucose >25 mg/dl). All subjects of both groups were subjected to full history taking and clinical examination including measurement of body mass index (BMI). Measurement of fasting blood glucose was done for all patients on the day of exercise. Measurements of liver function tests including serum level of Aspartate amino transferase (AST), Alanine aminotransferase (ALT), Gamma Glutamic transpeptidase (GGT), Alkaline phosphatase (Alk P), total protein (TP) and albumin were done immediately before exercise session and immediately after. Biochemical measurements were done using Hitachi 917-Auto analyzer (Roch diagnostics- Germany). Percent of changes post than pre exercise values were calculated as follows: % change = (Pre exercise value-post exercise value)/pre exercise value X1. Exercise protocol: Exercise session was started immediately after withdrawal of blood sample using electronic bicycle ergometer (mod TF-6.2E China). The exercise session was a twenty minutes procedure that was divided into three stages. First stage (warming up): Consisted of five minutes warming up in the form of pedaling at a speed of 6 revolutions/m without a load. Second stage (active stage): Consisted of light intensity exercise in the form of pedaling at a speed of 6 revolutions/m with a load adjusted to achieve reported effort using the Borg scale for rating of perceived exertion. Third stage (cooling down): Consisted of five minutes of cooling down in the form of pedaling at a speed of 6 revolutions/m without a load [12,13]. Statistical methods: Numeric data were presented in the form of mean±sd. Categorical data were summarized in the form of frequencies. Comparison
3 Yasser M. Abd El -Hamid & Aza F. Ismail 93 of paired data was done using paired sample t-test. Comparison of unpaired data was done using Mann- Whitney non parametric test. Pearson correlation was done to detect strength of association between variable. Statistical significance was considered at p<.5. All p values were two sided. Statistical analysis was done using Microsoft excel and SPSS version 11.. Results Mean values of all measured liver enzymes were found to significantly higher in diabetic patients than controls while mean serum total proteins and albumin were found to be significantly lower in diabetics both pre and post exercise (Table 1). All measured liver function tests were found to have significantly higher mean values post exercise than pre exercise in both groups of patients (Figs. 1,2). Comparison of mean percent of change of liver function tests revealed significantly higher values for AST, ALT, GGT, Alkaline phosphatase and significantly lower values for albumin and total protein in control group than diabetic patients (Fig. 3). Mean age was not significantly different between groups. Age was not significantly correlated with any of the parameters of liver functions studied both in diabetic patients and control subjects. In addition, there was no difference between males and females in all parameters studied in both groups p=.2 p=.4 Pre exercise Post exercise AST ALT Alk P GGT TP Albumin AST ALT Alk P GGT TP Albumin Aspartate aminotrasferase, ALT: Alanine aminotrasferase, Fig. (1): Comparison of studied liver function tests post exercise than pre exercise values in diabetic patients p=.4 p=.6 Pre exercise Post exercise p=.2 p=.3 AST: Aspartate aminotrasferase, ALT: Alanine aminotrasferase, Fig. (2): Comparison of studied liver function tests post exercise than pre exercise values in control group AST ALT Alkaline P GGT TP Albumin p=.3 p=.1 p<.1 p=.7 Group 1 Group 2 p=.4 AST: Aspartate aminotrasferase, ALT: Alanine aminotrasferase, Fig. (3): Comparison of percent of change in liver function tests between group 1 (diabetic patients) and group 2 (normal subjects). Discussion Aerobic exercises are an important part of life style measures designed for treatment of diabetes mellitus [14]. Patients with type 2 diabetes are at increased risk of liver damage [15]. They have a higher incidence of liver function test abnormalities than individuals who do not have diabetes [16]. Chronic HCV infection has been linked to diabetes mellitus in several studies [17,18]. So the objective of this study was to evaluate the immediate effect of aerobic exercise on biochemical liver function tests in patients with type 2 diabetes. This objective was accomplished through a cross sectional study assessing ALT, AST, GGT, Alkaline phosphates, total protein and albumin both pre and post a light form of bicycle based exercise for 2 minutes. In the current study, all studied liver enzymes were found to be significantly higher in diabetic patients than controls. Individuals with type 2 diabetes had a higher incidence of liver function tests abnormalities. Mild chronic elevation of liver enzymes was
4 94 Response of Liver Function Tests to Aerobic Exercise found to reflect insulin resistance which is an integral part of the pathogenesis of type 2 diabetes [19,2]. Non alcoholic fatty liver is one of the complications of diabetes mellitus that could present with elevated liver enzymes [21]. Serum albumin and total protein were found to be significantly lower in diabetic patients which could be explained by the well known effect of diabetic nephropathy causing albumin loss in urine even in the newly diagnosed cases [22]. Significant increase of all studied liver enzymes post exercise was found in our study both in diabetic patients and normal controls. These results go with what was found previously in elevation of liver function tests following exercise such as AST, ALT and alkaline phosphates [23]. There is no consensus on what form of exercise can cause clinical change in liver function biochemical tests. Running [24] and weight lifting [2] were found to produce such an effect. In our study, serum albumin and total proteins were found to be significantly increased post exercise both in diabetic patients and controls. Expansion of plasma volume at the expense of extravascular volume was reported due to increased synthesis of plasma proteins mainly albumin post exercise resulting in increase in plasma oncotic pressure [25]. The significant elevation of all studied liver enzymes post exercise both in diabetic patients and controls found in our study did not signify a specific effect of diabetes on liver enzymes. Moreover, changes of liver functions post exercise were found to be significantly higher in control subjects. Both our diabetic patients and controls had a mild form of obesity with significantly higher mean BMI in control subjects than diabetic patients. Obesity was reported by many investigators to cause elevated levels of liver enzymes including ALT, AST, GGT and Alkaline phosphatase [26-29]. This presumed effect of obesity on liver enzymes in control group could be responsible for our failure to get a specific effect of diabetes on change of liver functions post exercise. Elevated ALT and AST activity were found to be associated with increased fasting insulin and not with obesity per se suggesting that the presence of insulin resistance, rather than BMI alone, plays a role in mediating the increased aminotransferase activity [3]. Fasting hyperinsulinemia is on of the pathogenic features that characterize insulin resistance which eventually progress to the frank form of diabetes mellitus [31]. Conclusion: Light intensity exercise can cause immediate elevation of AST, ALT, GGT, Alkaline phosphatase, total proteins and albumin serum levels both in patients with type 2 diabetes mellitus and in non diabetic subjects. No clear immediate effect of diabetes mellitus on changes of liver function tests post exercise could be detected. Further studies on a larger number of patients and with a longer follow up period are recommended to clarify this point. Acknowledgement: To Dr. Yasmine T. Elshewi, Assistant Professor of Chemical Pathology, Faculty of Medicine-Cairo University and to Sara S. Zakaria, Specialist of Physical Therapy-Cairo University. References 1- PARIKH D.J. and RAMANTHAN N.L.: Exercise induced serum enzyme changes in untrained subjects. Indian J. Physiol. Phamacol., 21 (3): 175, PETTERRSSON J., HINDORF U., PERSSON P., et al.: Muscular exercise can cause highly pathological liver function tests in healthy men. Br. J. Clin. Pharmacol., 65 (2): 253, NIKOLAEVA L.F., AZHMUKHANBETOVA A.Z.H., TITOV V.H., et al.: Value of determining serum enzyme activity during the exercise test in evaluating the functional condition of patients with ischemic heart disease and concomitant diabetes mellitus. Kardiologiia, 28 (11): 85, KEIICHIOR Y.: Exercise and liver injury. J. Kan. Tan. Sui., 46 (2): 217, SREENIVASA BABA C., ALEXANDER G., KALYANI B., et al.: Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J. Gastroenterol. Hepatol., 21 (1): 191, JUUL A., SUTEDJA D., JOHNSON J., et al.: Treatment of nonalcoholic steatohepatitis: The effect of regular exercise. European Journal of Sport Science, 3 (4): 1, American Diabetes Association: Physical activity/exercise and diabetes. Diabetes Care, 27: (suppl 1) S58, SNOWLING N.J. and HOPKINS W.G.: Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care, 29: 2518, FISHER J.S., GAO J., HAN D.H., et al.: Activation of AMP kinase enhances muscle glucose transport to insulin. AM J. Physiol Endocrinol Metab, 282: E18, ANGULO P., KEACH J.C., BATTS K.P., et al.: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology, 3: 1356, MEHTA S.H., BRANCATI F.L., SULKOWSKI M.S., et al.: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med., 133: 592, WHALEY M.H., KAMINSKY L.A., DWYER G.B., et al.: Predictors of over-and under-achievement of agepredicted maximal heart rate. Med. Sci. Sports Exerc, 24 (1): 1173, 1992.
5 Yasser M. Abd El -Hamid & Aza F. Ismail Borg's Perceived Exertion and Pain Scales. Champaign, IL: Human Kinetics, 24, YAMANOUCHI K., SHINOZAKI T., CHIKADA K., et al.: Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care, 18: 775, BELCHER G. and SCHERNTHANER G.: Changes in liver tests during 1-year treatment of patients with type 2 diabetes with pioglitazone, metformine or gliclazide. Diabet Med., 22: 973, MARCHESINI G., AVAGNINA S., BARANTANI E.G., et al.: Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J. Endocrinol Invest., 28 (4): 333, MEHTA S.H., BRANCATI F.L., STRATHDEE S.A., et al.: Hepatitis C virus infection and incident type 2 diabetes. Hepatology, 38: 5, ZEIN C.O., LEVY C., BASU A., et al.: Chronic hepatitis C and type II diabetes mellitus: a prospective crosssectional study. Am. J. Gastroenterol, 1: 48, LEWIS G.F., CARPENTEIR A., KHOSROW A., et al.: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev., 23 (2): 21, STUMVOLL M., GOLDSTEIN B.J. and Van HAEFTEN T.W.: Type 2 diabetes: Principles of pathogenesis and therapy. Lancet, 365: 1333, VUPPALANCHI R. and CHALASANI N.: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology, 49 (1): 36, ALDER A.I., STEVENS R.J., MANLEY S.E., et al.: Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int., 63: 225, IKUYAMA T., WATANABE T., MINEGISHI Y., et al.: H. Effect of voluntary exercise on 3'-methyl-4- dimethylaminoazobenzene-induced hepatomas in male Jc1: Wistar rats. Proc-Soc-Exp-Biol-Med., 24 (2): 211, SMITH J.E., GARBUTT G., LOPES P., et al.: Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br. J. Sports Med., 38 (3): 292, ROCKER, KIRSCH K.A. and STOBOY H.: Plasma volume, albumin and globulin concentration and their intravascular masses. European Journal of Applied Physiology and occupational physiology, 36 (11): 57, SALVAGGIO A., PERITI M., MIANO L., et al.: Body mass index and liver enzyme activity in serum. Clin. Chem., 37 (5): 72, GOLIK A., RUBIO A., WEINTRAUB M., et al.: Elevated serum liver enzymes in obesity: A dilemma during clinical trials. Int. J. Obes., 15 (12): 797, RUHL C.E. and EVERHART J.E.: Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology, 124 (1): 71, HERMOS J.A., COHEN S.A., HALL R., et al.: Association of elevated alanine aminotransferase with BMI and diabetes in older veteran outpatients. Diabetes Res. Clin. Pract., 8 (1): 153, LACOBELLIS G., MOSCHETTA A., BUZZETTI R., et al.: Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin. Nutr Metab Cardiovasc Dis., 17 (6): 442, WEYER C., BOGARDUS C., MOTT D.M., et al.: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest., 14: 787, 1999.
Background of the FIB-4 Index in Japanese Non-Alcoholic Fatty Liver Disease
ORIGINAL ARTICLE Background of the FIB-4 Index in Japanese Non-Alcoholic Fatty Liver Disease Takashi Wada and Mikio Zeniya Abstract Objective We investigated the distribution and characteristics of the
More informationHepatitis C Virus Infection in Diabetes Mellitus Patients
599 Hepatitis C Virus Infection in Diabetes Mellitus Patients Han Ni*, Soe Moe, Aung Htet 1 Assistant Professor, Department of Medicine, Melaka Manipal Medical College, Malaysia 2 Associate Professor,
More informationWhat is NAFLD?.NASH? Presenter Disclosure Information. Learning Objectives. Case 1: Rob. Questions Pertinent to Rob
Presenter Disclosure Information 5 6pm Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic SPEAKER Elliot Tapper, MD The following relationships exist related to this presentation:
More informationInternational Journal Of Basic And Applied Physiology
COMPARATIVE STUDY OF LIVER FUNCTION TESTS IN DIABETES TYPE-2 PATIENTS AND NON-DIABETICS IN GUJARAT Vishaldeep D Gohel*, Betsy Johnson**, Varsha Joshi***, *Tutor,**2 nd Year resident,*** Head of department,
More informationThe role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis
The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis Objectives: Liver biopsy is the gold standard for diagnosing the extent of fibrosis in NAFLD/NASH;
More informationEVALUATION OF ABNORMAL LIVER TESTS
EVALUATION OF ABNORMAL LIVER TESTS MIA MANABAT DO PGY6 MOA 119 TH ANNUAL SPRING SCIENTIFIC CONVENTION MAY 19, 2018 EVALUATION OF ABNORMAL LIVER TESTS Review of liver enzymes vs liver function tests Clinical
More informationLaboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011
Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled
More informationMETABOLIC SYNDROME AND HCV: FROM HCV
METABOLIC SYNDROME AND HCV: FROM THEORY TO PRACTICE HCV Steatosis Insulin resistance Arun J Sanyal M.D. Chairman, Div. of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University Richmond,
More informationJMSCR Vol 04 Issue 12 Page December 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.67 Comparative Study of Liver Function
More informationNormal ALT for men 30 IU/L 36% US males abnormal. Abnl ALT. Assess alcohol use/meds. Recheck in 6-8 weeks. still pos
Fatty liver disease Its not just for big boys anymore Ken Flora, MD, FAASLD, FACG, AGAF No disclosures Common situation Normal ALT for men 30 IU/L 36% US males abnormal Normal ALT for women 20 IU/L 28%
More informationThe effect of aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non-alcoholic fatty liver disease
Gastroenterology and Hepatology From Bed to Bench. 2013 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE The effect of aerobic exercise on serum level of liver enzymes
More informationNONALCOHOLIC FATTY LIVER DISEASE. Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD. April 13, 2012
NONALCOHOLIC FATTY LIVER DISEASE Kiran Bambha, MD University of Colorado Denver April 13, 2012 Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD Simple Steatosis Fatty hepatocytes Intracellular fat
More informationAmerican Journal of Oral Medicine and Radiology
American Journal of Oral Medicine and Radiology e - ISSN - XXXX-XXXX ISSN - 2394-7721 Journal homepage: www.mcmed.us/journal/ajomr PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE AMONG TYPE 2 DIABETIC POPULATION
More informationManagement of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France
Management of autoimmune hepatitis Pierre-Emmanuel RAUTOU Inserm U970, PARCC@HEGP, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France Case 1 52 year-old woman, referred for liver blood tests
More information/ FIB4 Index , simple steatosis. FIB4 Index. FIB4 Index. FIB4 Index FIB4 Index. Sterling FIB4 Index. FIB4 Index AST AST ALT
原 著 29 34-41, 2014 FIB4 Index 1 1 1 1 2 1 1 FIB4 Index FIB4 Index cut off 2.67 2.67 12,059 FIB4 IndexFIB4 Index 2.67 / FIB4 Index AST ALT FIB4 Index 2.67 161 1.3% FIB4 Index 5 FIB4 Index 1.1 5 1.6 FIB4
More informationJournal of Adolescent Health 42 (2008) Original article. Manuscript received September 5, 2007; manuscript accepted November 27, 2007
Journal of Adolescent Health 42 (2008) 543 548 Original article Presence of the Metabolic Syndrome in Obese Adolescents Predicts Impaired Glucose Tolerance and Nonalcoholic Fatty Liver Disease Kathy A.
More informationA STUDY ON SERUM URIC ACID AND LIVER ENZYMES IN THE GERIATRIC AGE GROUP IN A TERTIARY CARE HOSPITAL
Biochemistry Original Article International Journal of Clinical And Diagnostic Research ISSN 2395-3403 Volume 6, Issue 3, May-June 2018 A STUDY ON SERUM URIC ACID AND LIVER ENZYMES IN THE GERIATRIC AGE
More informationRole of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease
Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease X. Lin 1,2, Z. Zhang 2, J.M. Chen 2, Y.Y. Xu 2, H.R. Ye 2, J. Cui 2, Y. Fang 2, Y. Jin 2, D.R. Zhu 2 and
More informationAt Least 1 in 5 Patients in Your Practice Have Fatty Liver
At Least 1 in 5 Patients in Your Practice Have Fatty Liver What Can You Tell Your Patients Magnus McLeod MD FRCPC Assistant Professor Dalhousie University 30-NOV-2017 NAFLD Non-Alcoholic Fatty Liver Disease
More informationDownloaded from zjrms.ir at 3: on Monday February 25th 2019 NAFLD BMI. Kg/m2 NAFLD
logistic regression Student s t-test P< BMI BMI P< ALT AST P< Email:mkhoshbaten@yahoo.com Kg/m2 NASH RUQ B C II Case-Control II Logistic Regression Chi-Square T-test P< Grade Model 1- A diffuse hyper echoic
More informationStudy of significance of glycosylated hemoglobin in diabetic patient
Original Research Article Study of significance of glycosylated hemoglobin in diabetic patient Dimpal Modi 1*, Gunvanti B. Rathod 2, K. N. Delwadia 3, H. M. Goswami 4 1 Tutor, Pathology Department, GMERS
More informationALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche,
Supplemental Methods Analytical determinations ALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche, Basel, Switzerland). Glucose, triglyceride, total
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.63 Insulinemic Status and Nonalcoholic
More informationORIGINAL ARTICLE. Abstract. Introduction
ORIGINAL ARTICLE Prognostic Factors for Regression from Impaired Glucose Tolerance to Normal Glucose Regulation in Japanese Patients with Nonalcoholic Fatty Liver Disease Chie Ogata, Yuki Ohmoto-Sekine,
More informationDecrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet ( )
486 ORIGINAL ARTICLE October-December, Vol. 10 No.4, 2011: 486-492 Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet ( ) Heriberto Rodríguez-Hernández,*
More informationEFFECT OF ORAL SUPPLEMENTATION OF WHEY PROTEIN ISOLATE ON NON-ALCOHOLIC STEATOHEPATITIS PATIENTS
42 EFFECT OF ORAL SUPPLEMENTATION OF WHEY PROTEIN ISOLATE ON NON-ALCOHOLIC STEATOHEPATITIS PATIENTS Prasong Tienboon MD, PhD. 1, Taned Chitapanarux MD. 2, Suwalee Pojchamarnwiputh MD. 3, Donrawee Leelarungrayub
More informationDisclosure. Objectives. Smash the Nash: A practical approach to fatty liver disease
Smash the Nash: A practical approach to fatty liver disease Bruce D. Askey, MS, ANP-BC Associate Lecturer North Andover, MA Adult Nurse Practitioner Dept. of Hepatology/Gastroenterology Guthrie Clinic
More informationImproving Access to Quality Medical Care Webinar Series
Improving Access to Quality Medical Care Webinar Series Presented by The Arizona Telemedicine Program and the Southwest Telehealth Resource Center 2015 UA Board of Regents Welcome AZ, UT, CO, NM & NV FLEX
More informationThe classical metabolic work-up, approved by the Ethics Committee of the Antwerp
SUPPLEMENTARY MATERIALS METHODS Metabolic work-up The classical metabolic work-up, approved by the Ethics Committee of the Antwerp University Hospital and requiring written informed consent, included a
More informationNon-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver Disease None Disclosures Arslan Kahloon M.D Chief, Division of Gastroenterology and Hepatology University of Tennessee College of Medicine Chattanooga Objectives Understand the
More informationThe relation between weight changes and alanine aminotransferase levels in a nonalcoholic population
The relation between weight changes and alanine aminotransferase levels in a nonalcoholic population Ji Eun Yun Department of Public Health The Graduate School Yonsei University The relation between weight
More informationOld oral antidiabetic agents in the armamentarium of diabetes mellitus treatment: Safety and efficacy
Old oral antidiabetic agents in the armamentarium of diabetes mellitus treatment: Safety and efficacy Melpomeni Peppa Assistant Professor of Endocrinology 2 nd Dept of Internal Medicine-Propaedeutic, Athens
More informationFREQUENCY OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS BIOCHEMICAL DERANGEMENTS IN TYPE II DIABETIC PATIENTS
FREQUENCY OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS BIOCHEMICAL DERANGEMENTS IN TYPE II DIABETIC PATIENTS DR. ABDUL JABBAR, MBBS DR. ABDUL BASIT, MBBS DR. HAFIZ MUHAMMAD HANNAN AKBAR, MBBS ABSTRACT
More informationNAFLD/NASH. Definitions. Pathology NASH. Vicki Shah PA-C, MMS Rush University Hepatology
NAFLD/NASH Vicki Shah PA-C, MMS Rush University Hepatology Definitions NAFLD Evidence of hepatic steatosis by histology (5%) or imaging No causes for secondary fat accumulation EtOH, Drugs, hereditary
More informationSupplementary materials
Supplementary materials Table S Adverse events identified by participants diary logs and blood hematologic and biochemical tests (n=2) group (n=) Placebo group (n=) P value for chi-squared test Asthma
More informationDietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and
Dietary supplementation in treating non-alcoholic fatty liver disease Dr. Ahmad Saedi Associate Professor School of Nutritional Sciences and Dietetics Tehran University of Medical Sciences Honorary Academic
More informationNonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse
Nonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH Nonalcoholic steatohepatitis
More informationPancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis
Pancreatic exocrine insufficiency: a rare cause of nonalcoholic steatohepatitis Naoki Tanaka 1, Akira Horiuchi 2, Takahide Yokoyama 3, Shigeyuki Kawa 1, and Kendo Kiyosawa 1 1 Department of Gastroenterology,
More informationPrevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar
Original Research Article Prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus patients in a tertiary care hospital of Bihar Naresh Kumar 1, Jyoti Kumar Dinkar 2*, Chandrakishore
More informationUMHS-PUHSC JOINT INSTITUTE
Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,
More informationNON-ALCOHOLIC FATTY LIVER DISEASE:
NON-ALCOHOLIC FATTY LIVER DISEASE: ROLE OF THE PRIMARY PROVIDER Archita P. Desai, MD Assistant Professor of Medicine University of Arizona 25 th Annual Southwestern Conference on Medicine Outline Pathophysiology
More informationImpact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients
2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type
More informationAASLD Immune tolerant phase HBV NAFLD diagnostic HCC
AASLD 2016 Immune tolerant phase HBV NAFLD diagnostic HCC Immune tolerant 3 Modified from Chan HLY and Wong VWS. Hepatitis B. In Zakim and Boyers s Hepatology 2012 2015 AMERICAN ASSOCIATION FOR THE S1T6UDY
More informationIndianJournals.com ABSTRACT INTRODUCTION
Indian Journal of Mednodent and Allied Sciences Vol. 4, No. 3, November 2016, pp- 107-111 IndianJournals.com A product of Diva Enterprises Pvt. Ltd. DOI : 10.5958/2347-6206.2016.00017.0 Original Research
More informationUpdate on Non-Alcoholic Fatty Liver Disease. Timothy R. Morgan, MD Chief, Hepatology, VA Long Beach Professor of Medicine, UCI
Update on Non-Alcoholic Fatty Liver Disease Timothy R. Morgan, MD Chief, Hepatology, VA Long Beach Professor of Medicine, UCI February 3, 2018 Disclosure Clinical trials: Genfit Speaker s Bureau: none
More informationDevelopment and validation of a simple index system to predict nonalcoholic fatty liver disease
The Korean Journal of Hepatology 2011;17:19-26 DOI: 10.3350/kjhep.2011.17.1.19 Original Article Development and validation of a simple index system to predict nonalcoholic fatty liver disease Young Jin
More informationUpdate on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic
Update on Nonalcoholic Fatty Liver Disease Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic Outline Defining the phenotypes of nonalcoholic fatty liver disease NAFLD Diagnostics
More informationHepatology for the Nonhepatologist
Hepatology for the Nonhepatologist Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Cincinnati, Ohio Learning
More informationFat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy
Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Goals Share an interesting case Important because it highlights a common problem that we re likely to
More informationChallenges in the Diagnosis of Steatohepatitis
The Bugaboos of Fatty Liver Disease: Ballooning and Fibrosis Hans Popper Hepatopathology Society Companion Meeting San Antonio, Tx March, 2017 David Kleiner, M.D., Ph.D. NCI/Laboratory of Pathology Challenges
More informationCDHNF & NASPGHAN A Partnership for Research and Education for Children s Digestive and Nutritional Health
CDHNF & NASPGHAN A Partnership for Research and Education for Children s Digestive and Nutritional Health Obesity and NAFLD Definitions: Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver
More informationAAIM: GI Workshop Follow Up to Case Studies. Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease
AAIM: GI Workshop Follow Up to Case Studies Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease Daniel Zimmerman, MD VP and Medical Director, RGA Global October 2015 Non-alcoholic Fatty
More informationMetabolic Syndrome and HCC. Jacob George
Metabolic Syndrome and HCC Jacob George MetS and risk of HCC and ICC All with HCC and ICC between 1993 and 2005 identified in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. For
More informationWorld Gastroenterology Organisation Global Guidelines
WGO GUIDELINE Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Review Team, Douglas R. LaBrecque, MD, FACP (chair, USA), Zaigham Abbas, MD, MBBS, FCPS, FRCP, FRCPI, FACP, FACG, AGAF (Pakistan),
More informationInsulin Resistance in Patients with Chronic Hepatitis C Infection
Australian Journal of Basic and Applied Sciences, 4(10): 4554-4558, 2010 ISSN 1991-8178 Insulin Resistance in Patients with Chronic Hepatitis C Infection 1 Hoda Abd El-Satar MD. 1 Mahmoud Mahfouz MD. 2
More information대사증후군과알라닌아미노전이효소와의관련성 : 국민건강영양조사제 3 기 (2005 년 )
원저 대사증후군과알라닌아미노전이효소와의관련성 : 국민건강영양조사제 3 기 (2005 년 ) 한미아류소연박종강명근김기순 조선대학교의과대학예방의학교실 조선대학교내성세포연구센터 서론 alcoholic steatohepatitis NASH) 2 2 [1] 2001 NCEP-ATP III Panel [2] (nonalcoholic fatty liver disease
More informationPatients characteristics associated with better glycemic response to teneligliptin and metformin therapy in type 2 diabetes: a retrospective study
International Journal of Advances in Medicine Gadge PV et al. Int J Adv Med. 2018 Apr;5(2):424-428 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20181082
More informationAspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis
The Turkish Journal of Pediatrics 2015; 57: 492-497 Original Aspartate aminotransferase-to-platelet ratio index in children with cholestatic liver diseases to assess liver fibrosis Aysel Ünlüsoy-Aksu 1,
More informationEnergy Balance Equation
Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT
More informationInterpreting Liver Function Tests
PSH Clinical Guidelines Statement 2017 Interpreting Liver Function Tests Dr. Asad A Chaudhry Consultant Hepatologist, Chaudhry Hospital, Gujranwala, Pakistan. Liver function tests (LFTs) generally refer
More informationPatients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States
Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States Maria Stepanova, 1,2 Stephen Clement, 3 Robert Wong, 4 Sammy Saab,
More informationNAFLD AND TYPE 2 DIABETES
NAFLD AND TYPE 2 DIABETES Sonia Caprio, MD STOPNASH Symposium on the Origin and Pathways of Nonalcoholic Steatohepatitis Washington 7, 215 Global Projection of Diabetes Hossain P et al. N Engl J Med 27;356:213
More informationPEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE
PEDIATRIC FOIE GRAS: NON-ALCOHOLIC FATTY LIVER DISEASE Updates on New insights into NAFLD and NASH pathophysiology New AASLD/AGA/ACG guidelines for NAFLD and NASH, as pertains to pediatrics Evidence-based
More informationLiver Pathology in the 0bese
Liver Pathology in the 0bese Rob Goldin Centre for Pathology, Imperial College r.goldin@imperial.ac.uk Ludwig et al. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
More informationFatty liver disease in Sudan is not alcohol related Nail A M 1, Gadour MO 2, Khair MM 3, Salma BM 4, Suzan E 5
Fatty liver disease in Sudan is not alcohol related Nail A M 1, Gadour MO 2, Khair MM 3, Salma BM 4, Suzan E 5 Abstract: Background: The finding of fatty liver disease (FLD) has generally been assumed
More informationPhysical Activity and the Prevention of Type 2 Diabetes Mellitus How Much for How Long?
CURRENT OPINION Sports Med 2000 Mar; 29 (3): 147-151 0112-1642/00/0003-0147/$20.00/0 Adis International Limited. All rights reserved. Physical Activity and the Prevention of Type 2 Diabetes Mellitus How
More informationtage Percent Total & over Total & over Men Women Men Women
Paul Angulo, MD, FACG, AGAF Professor of Medicine, Section Chief of Hepatology Division i i of Digestive i Diseases and Nutrition i University of Kentucky Medical Center Lexington, KY Paul Angulo, MD University
More informationAlarming high levels of transaminases in non insulin dependent diabetes mellitus
Original article: Alarming high levels of transaminases in non insulin dependent diabetes mellitus *Ekta Chitkara Department of Applied Medical Sciences, Lovely Professional University, Punjab, India *Corresponding
More informationSignificance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease
ORIGINAL ARTICLE Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver Disease Hisamitsu Miyaaki 1, Tatsuki Ichikawa 1,NaotaTaura 1, Satoshi Miuma
More informationDoes metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both?
Diabetologia (2013) 56:2378 2382 DOI 10.1007/s00125-013-3026-6 SHORT COMMUNICATION Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both? Normand G. Boulé
More informationPrevalence of non-alcoholic fatty liver disease among obese children in North Kerala, India
International Journal of Contemporary Pediatrics Reetha G et al. Int J Contemp Pediatr. 2017 May;4(3):1051-1055 http://www.ijpediatrics.com pissn 2349-3283 eissn 2349-3291 Original Research Article DOI:
More informationCHRONIC HCV TREATMENT: In Special Populations.
CHRONIC HCV TREATMENT: In Special Populations. By Taher EL-ZANATY Prof. of Internal Medicine CAIRO UNIVERSITY Introduction: HCV is the major cause of chronic hepatitis in Egypt. Its end stage is liver
More informationOriginal Article. Significance of Hepatic Steatosis in Chronic Hepatitis B Infection INTRODUCTION
Original Article Bhanthumkomol P, et al. THAI J GASTROENTEROL 2013 Vol. 14 No. 1 Jan. - Apr. 2013 29 Bhanthumkomol P 1 Charatcharoenwitthaya P 1 Pongpaiboon A 2 ABSTRACT Background: Significance of liver
More informationMonitoring Hepatitis C
Monitoring Hepatitis C Section Six Monitoring Hepatitis C Screening for hepatitis C is not routinely done, so you may have to request a test from your medical provider. This usually involves an antibody
More informationTransient elastography in chronic liver diseases of other etiologies
4 Post Meeting A.I.S.F. Unmet Clinical Needs in Hepatology: New and upcoming diagnostic tools" Transient elastography in chronic liver diseases of other etiologies Dr. Vincenza Calvaruso Gastroenterologia
More informationThe role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases
RESEARCH ARTICLE The role of ARFI and APRI in diagnosis of liver fibrosis on patients with common chronic liver diseases Objective: This study aimed to investigate the value of liver fibrosis assessment
More informationNon-Alcoholic Fatty Liver Disease (NAFLD)
HEPATO-PANCREATO-BILIARY STOMACH CANCER PROGRAM Non-Alcoholic Fatty Liver Disease (NAFLD) Steatosis and Non-Alcoholic Steatohepatitis (NASH) Management Recommendations UCSF Fresno Department of Surgery
More informationThe Skinny On Non Alcoholic Fatty Liver Disease
The Skinny On Non Alcoholic Fatty Liver Disease UCSF Advances in Internal Medicine Monika Sarkar, MD, MAS UCSF Division of GI/Hepatology June 24th, 2015 Non Alcoholic Fatty Liver Disease: Outline Pathogenesis
More informationNIH Public Access Author Manuscript Am J Med Sci. Author manuscript; available in PMC 2015 January 01.
NIH Public Access Author Manuscript Published in final edited form as: Am J Med Sci. 2014 January ; 347(1):. doi:10.1097/maj.0b013e31828b25a5. Association Between Metabolic Syndrome and Its Individual
More informationNon alcoholic fatty liver and Non alcoholic Steatohepatitis. By Dr. Seham Seif
Non alcoholic fatty liver and Non alcoholic Steatohepatitis By Dr. Seham Seif Definition NAFL describe a common clinicopathological conditions characterized by significant lipid deposition in the hepatocytes
More informationPatterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Outline liver function tests / tests of
More informationWHAT CAN YOU USE IN YOUR CLINIC TODAY FOR THE TREATMENT OF NASH?
WHAT CAN YOU USE IN YOUR CLINIC TODAY FOR THE TREATMENT OF NASH? Helena Cortez-Pinto Laboratório de Nutrição, FML, Serviço de Gastrenterologia, Hospital St Maria, Lisboa, Portugal EASL Governing Board:
More informationEarly life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016.
Early life determinants of Non-Alcoholic Fatty Liver Disease and NASH DR JULIANA MUIVA-GITOBU KENYA PAEDIATRIC ASSOCIATION CONFERENCE APRIL 2016. Outline Definition NAFLD and NASH Magnitude of the problem
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-25 U/L 10-35 U/L 10-30 U/L 10-25 U/L 10-30 U/L 10-35 U/L 10-25 U/L 10-35 U/L 10-25 U/L 10-20 U/L 10-35 U/L Albumin 0-6
More informationChemistry Reference Ranges and Critical Values
Alanine Aminotransferase (ALT, SGPT) 3-9 years 9-18 years 1-9 years 9-18 years 10-30 U/L 10-30 U/L 10-20 U/L Albumin 0-6 days 6 days - 37 months 37 months - 7 years 7-20 years 2.6-3.6 g/dl 3.4-4.2 g/dl
More informationNational Horizon Scanning Centre. Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis. June 2008
Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis June 2008 This technology summary is based on information available at the time of research and a limited literature search. It is not intended
More informationCase #1. Digital Slides 11/6/ year old woman presented with abnormal liver function tests. Liver Biopsy to r/o autoimmune hepatitis
45 year old woman presented with abnormal liver function tests Liver Biopsy to r/o autoimmune hepatitis Further down. ANA 1: 160; ASMA 1:80 ANA 1: 160; ASMA 1:80 IgG = 14.5 g/l (upper normal range: 16)
More informationHYPOGLYCAEMIC ACTION OF THE FLAVONOID FRACTION OF ARTOCARPUS HETEROPHYLLUS LEAF
42 Research Paper ISSN 0189-6016 2006 Afr. J. Traditional, Complementary and Alternative Medicines www.africanethnomedicines.net HYPOGLYCAEMIC ACTION OF THE FLAVONOID FRACTION OF ARTOCARPUS HETEROPHYLLUS
More informationAbdominal Obesity and Fatty Liver
Epidemiologic Reviews Copyright ª 2007 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A. Vol. 29, 2007 DOI: 10.1093/epirev/mxm002 Advance Access publication
More informationChapter 37: Exercise Prescription in Patients with Diabetes
Chapter 37: Exercise Prescription in Patients with Diabetes American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationLiver Enzymes Concentrations Are Closely Related to Pre diabetes: Findings of the Shanghai Diabetes Study II (SHDS II) *
30 Biomed Environ Sci, 2012; 25(1): 30 37 Original Article Liver Enzymes Concentrations Are Closely Related to Pre diabetes: Findings of the Shanghai Diabetes Study II (SHDS II) * GAO Fei 1, PAN Jie Min
More informationNAFLD & NASH: Russian perspective
NAFLD & NASH: Russian perspective Vasily Isakov, MD, PhD Professor, Chief, Department Gastroenterology & Hepatology, Federal Research Center of nutrition, biotechnology and food safety Disclosures Received
More informationIL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA
UNIGASTRO Il fegato come centrale metabolica e i fattori di danno oltre ai virus epatitici IL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA Dr Elisabetta Bugianesi Divisione di Gastro-Epatologia
More informationClinical Case. Ana Carolina Cardoso, MD Federal University of Rio de Janeiro - Brazil
Clinical Case Ana Carolina Cardoso, MD Federal University of Rio de Janeiro - Brazil Disclosures Nothing to declare - A 55-year-old female, asymptomatic, underwent abdominal ultrasound that revealed severe
More informationFatty liver disease: What do we know?
Fatty liver disease: What do we know? Prof. Dr. Claus Niederau Katholische Kliniken Oberhausen ggmbh St. Josef-Hospital Academic Teaching Hospital University of Duisburg-Essen NAFLD Non-Alcoholic Fatty
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationKeywords: NASH, insulin resistance, metformin, histopathology. William W. Shields, K.E. Thompson, G.A. Grice, S.A. Harrison and W.J.
Therapeutic Advances in Gastroenterology Original Research The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis
More informationDIABETES AND LABORATORY TESTS. Author: Josephine Davis
DIABETES AND LABORATORY TESTS Author: Josephine Davis LAB TESTS Think twice before you test. What is the reason for testing? Laboratory tests are generally requested in primary care for one of the following
More informationCIRROSI E IPERTENSIONE PORTALE NELLA DONNA
Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di
More informationIn Search of New Biomarkers for Nonalcoholic Fatty Liver Disease
REVIEW In Search of New Biomarkers for Nonalcoholic Fatty Liver Disease Ting-Ting Chan, M.R.C.P., and Vincent Wai-Sun Wong, M.D. Nonalcoholic fatty liver disease (NAFLD) affects 15% to 40% of the general
More information